Syracuse DePuy ASR Hip Implant Lawyers Review Timing of Recall In New York
DePuy (pronounced "DePew") Orthopedics is the manufacturer of several medical devices, including the ASR XL Acetabular System and the DePuy ASR Hip Resurfacing System, which were sold in the United States beginning in 2005. Between 2005 and August 24, 2010 - when DePuy publicly recalled approximately 93,000 devices - the Company and the FDA received numerous complaints about device failures, including dislocation and fracture.
According to Syracuse DePuy hip recall lawyer Michael A. Bottar, Esq., an attorney with Bottar Leone, PLLC, a team of trial lawyers handling several New York DePuy defective hip lawsuits, "DePuy has reported that as many as 1 in 8 people (12-13%) who received a DePuy hip replacement device will need a "revision" within five (5) years. A "revision" is a second surgery to remove the DePuy device and replace it with a different product." According to reports, this revision rate is higher than in similar implants manufactured by DePuy's competitors.
Bottar added, "[w]e are concerned about the timing of the recall. Apparently, DePuy stopped selling these products in Australia long before the U.S. recall in August of 2010." We need to know why DePuy thought it prudent to continue implant sales in the United States after it terminated sales elsewhere in the world.
"DePuy will have to answer tough questions in Court." Our New York product liability lawyers want to know why DePuy did not do more, sooner, especially where its failing metal-on-metal products may lead to metallosis or cobaltism. DePuy hip implant recipients diagnosed with metallosis, or those with a DePuy hip who have been diagnosed with cobaltism may be at risk for health problems.
Continue reading "Syracuse DePuy ASR Hip Implant Lawyers Review Timing of Recall In New York" »


